376 related articles for article (PubMed ID: 17922683)
1. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas.
Sato T; Murakumo Y; Hagiwara S; Jijiwa M; Suzuki C; Yatabe Y; Takahashi M
Pathol Int; 2007 Nov; 57(11):719-24. PubMed ID: 17922683
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD109 in human cancer.
Hashimoto M; Ichihara M; Watanabe T; Kawai K; Koshikawa K; Yuasa N; Takahashi T; Yatabe Y; Murakumo Y; Zhang JM; Nimura Y; Takahashi M
Oncogene; 2004 Apr; 23(20):3716-20. PubMed ID: 15116102
[TBL] [Abstract][Full Text] [Related]
3. CD109 expression in squamous cell carcinoma of the uterine cervix.
Zhang JM; Hashimoto M; Kawai K; Murakumo Y; Sato T; Ichihara M; Nakamura S; Takahashi M
Pathol Int; 2005 Apr; 55(4):165-9. PubMed ID: 15826242
[TBL] [Abstract][Full Text] [Related]
4. Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas.
Zheng H; Tsuneyama K; Takahashi H; Miwa S; Nomoto K; Saito H; Masuda S; Takano Y
Anticancer Res; 2007; 27(1B):575-81. PubMed ID: 17348444
[TBL] [Abstract][Full Text] [Related]
5. CD109 expression in basal-like breast carcinoma.
Hasegawa M; Moritani S; Murakumo Y; Sato T; Hagiwara S; Suzuki C; Mii S; Jijiwa M; Enomoto A; Asai N; Ichihara S; Takahashi M
Pathol Int; 2008 May; 58(5):288-94. PubMed ID: 18429827
[TBL] [Abstract][Full Text] [Related]
6. CD34-positive stromal cells in primary lung carcinomas.
Nakayama H; Enzan H; Yamamoto M; Miyazaki E; Hidaka C; Okumichi T; Okumichi A; Kajihara H
Oncol Rep; 2003; 10(5):1313-6. PubMed ID: 12883699
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclooxygenase-2 in human lung carcinoma.
Wolff H; Saukkonen K; Anttila S; Karjalainen A; Vainio H; Ristimäki A
Cancer Res; 1998 Nov; 58(22):4997-5001. PubMed ID: 9823297
[TBL] [Abstract][Full Text] [Related]
8. CD109, a new marker for myoepithelial cells of mammary, salivary, and lacrimal glands and prostate basal cells.
Hasegawa M; Hagiwara S; Sato T; Jijiwa M; Murakumo Y; Maeda M; Moritani S; Ichihara S; Takahashi M
Pathol Int; 2007 May; 57(5):245-50. PubMed ID: 17493171
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
Lyda MH; Weiss LM
Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
[TBL] [Abstract][Full Text] [Related]
10. Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas.
Zhang H; Zhao Q; Chen Y; Wang Y; Gao S; Mao Y; Li M; Peng A; He D; Xiao X
Thorax; 2008 Apr; 63(4):352-9. PubMed ID: 18364444
[TBL] [Abstract][Full Text] [Related]
11. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J; Samija M; Juretić A; Sarcević B; Sobat H
Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
[TBL] [Abstract][Full Text] [Related]
12. Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage.
Ito T; Noguchi Y; Satoh S; Hayashi H; Inayama Y; Kitamura H
Mod Pathol; 1998 May; 11(5):437-43. PubMed ID: 9619596
[TBL] [Abstract][Full Text] [Related]
13. Expression of thyroid transcription factor-1 in normal and neoplastic lung tissues.
Nakamura N; Miyagi E; Murata S; Kawaoi A; Katoh R
Mod Pathol; 2002 Oct; 15(10):1058-67. PubMed ID: 12379752
[TBL] [Abstract][Full Text] [Related]
14. Expression of hnRNP B1 in four major histological types of lung cancers.
Hamasaki M; Kamma H; Wu W; Kaneko S; Fujiwara M; Satoh H; Haraoka S; Kikuchi M; Shirakusa T
Anticancer Res; 2001; 21(2A):979-84. PubMed ID: 11396191
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer.
Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534
[TBL] [Abstract][Full Text] [Related]
16. Expression of the laminin gamma2 chain in different histological types of lung carcinoma. A study by immunohistochemistry and in situ hybridization.
Määttä M; Soini Y; Pääkkö P; Salo S; Tryggvason K; Autio-Harmainen H
J Pathol; 1999 Aug; 188(4):361-8. PubMed ID: 10440745
[TBL] [Abstract][Full Text] [Related]
17. Expression of aquaporin 3 (AQP3) in normal and neoplastic lung tissues.
Liu YL; Matsuzaki T; Nakazawa T; Murata S; Nakamura N; Kondo T; Iwashina M; Mochizuki K; Yamane T; Takata K; Katoh R
Hum Pathol; 2007 Jan; 38(1):171-8. PubMed ID: 17056099
[TBL] [Abstract][Full Text] [Related]
18. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A
J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220
[TBL] [Abstract][Full Text] [Related]
19. Expression of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor in primary lung carcinomas.
Suzuki S; Suzuki T; Tsubochi H; Koike K; Tateno H; Krozowski ZS; Sasano H
Anticancer Res; 2000; 20(1A):323-8. PubMed ID: 10769675
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
